Scivita Medical Expands Collaboration with Boston Scientific
SUZHOU, China, March 26, 2024 /PRNewswire/ -- Recently, Scivita Medical
Technology Co., Ltd. ("Scivita Medical") and Boston
Scientific Corporation (NYSE: BSX), a leading global medical technology
company, joined hands again to sign an expanded strategic cooperation
arrangement.
Boston Scientific Completes CE Mark for EXALT™ Model B Single-Use Bronchoscope
Company to begin limited market release in Europe in June MARLBOROUGH, Mass., May 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT™ Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the...
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
ARTARMON, Australia, June 28, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that it has secured$75 million in equity financing from Boston Scientific Corporation (NYSE: BSX) and Redmile Group LLC to fund the final stages of development through commercializatio...
Boston Scientific Signs Strategic Alliance With Frankenman Medical Equipment Company
MARLBOROUGH, Mass. and SUZHOU, China, April 14, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX), a leading global medical device company, announced the signing of a strategic alliance with Frankenman Medical Equipment Company, a recognized leader with deep local market expertise in...
Boston Scientific Signs Agreement with Fukuda Denshi for Distribution of Neuromodulation Devices in Japan
TOKYO, Feb. 21, 2013 /PRNewswire/ -- (Feb. 20, 2013 US Time) Boston Scientific Corporation (NYSE: BSX) subsidiary Boston Scientific Japan K.K. has reached an agreement with Fukuda Denshi Co., Ltd. to market and sell the Boston Scientific Spinal Cord Precision Plus System and accessories throughout J...
Boston Scientific Launches New Implantable Defibrillation Lead In Europe And Asia
RELIANCE(R) 4-FRONT(TM) Lead Designed to Streamline Surgical Procedure for Treatment of Heart Failure and Sudden Cardiac Arrest PARIS, Sept. 24, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received regulatory approval to market the RELIANCE(R) 4-FRONT(TM) lead, its next gen...
